Advanced Biomed is trading 6.32% down at $9.15, with no clear catalyst identified.

  • The stock fell 6.42% to $9.77 on September 2, 2026.
  • No company-specific announcement, filing, earnings release, or regulatory catalyst has been identified for September 3, 2026; external coverage shows only prior news.
  • Broader markets and biotechnology stocks are higher, leaving the cause unclear; monitor for delayed filings or company news.